Related Experiment Video
Updated: Mar 11, 2026

Drug-induced Sensitization of Adenylyl Cyclase: Assay Streamlining and Miniaturization for Small Molecule and siRNA Screening Applications
Published on: January 27, 2014
Multiple-parameter Optimization in Drug Discovery: Example of the 5-HT1B GPCR
Robert Charles Glen1, Warren R J D Galloway1, David R Spring1
1University of Cambridge, Cambridge, Cambridgeshire UNITED KINGDOM.
Optimizing drug discovery involves complex multi-parameter challenges. This study details a 5-HT1B antagonist strategy, focusing on target drugability, molecular properties, and low Central Nervous System (CNS) penetration for optimized drug candidates.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Pharmacology
Background:
- Early-phase drug discovery presents significant challenges in identifying drugable targets and novel chemical structures.
- Optimizing molecules requires balancing multiple parameters, including biological activity and physicochemical properties.
Purpose of the Study:
- To describe a drug optimization strategy using 5-HT1B antagonists as an example.
- To illustrate approaches for designing high-affinity, selective molecules with controlled Central Nervous System (CNS) penetration.
Main Methods:
- Evaluation of target drugability for 5-HT1B receptors.
- Design of novel chemical structures with specific physicochemical properties.
- Optimization strategies focused on achieving high affinity, selectivity, and low CNS penetration.
Main Results:
- Demonstrated a successful drug optimization strategy for 5-HT1B antagonists.
- Generated molecules with high affinity and selectivity for the 5-HT1B target.
- Achieved optimized compounds with significantly reduced CNS penetration.
Conclusions:
- The presented strategy effectively addresses the multi-parameter optimization challenges in early drug discovery.
- Designing molecules with specific physicochemical properties is crucial for achieving desired pharmacological profiles, including controlled CNS penetration.
- This work provides a framework for developing optimized drug candidates targeting 5-HT1B receptors.
More Related Videos
09:03Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
GPCR Desensitization
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...